Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Harvard University · Kaiser Permanente · +2 more institutions
Abstract
To evaluate the effect of warfarin on risk of thromboembolism, hemorrhage, and death in atrial fibrillation within a usual care setting.
Cohort study assembled between July 1, 1996, and December 31, 1997, and followed up through August 31, 1999.
Citation impact
- FWCI
- 16.98
- Percentile
- 100%
- References
- 53
Authors
9- ASAlan S. GoCorresponding
Harvard University, Kaiser Permanente, Massachusetts General Hospital, San Francisco General Hospital
- EMElaine M. Hylek
Massachusetts General Hospital, San Francisco General Hospital, Kaiser Permanente, Harvard University
- YCYuchiao Chang
Massachusetts General Hospital, San Francisco General Hospital, Kaiser Permanente, Harvard University
- KAKathleen A. Phillips
San Francisco General Hospital, Harvard University, Massachusetts General Hospital, Kaiser Permanente
- LHLori Henault
San Francisco General Hospital, Massachusetts General Hospital, Kaiser Permanente, Harvard University
Topics & keywords
- Medicine
- Warfarin
- Atrial fibrillation
- Stroke (engine)
- Odds ratio
- Hazard ratio
- Internal medicine
- Antithrombotic
- Good health and well-being